Abigail Elizabeth Huang, MD in Portland, OR - Medicare Student in an Organized Health Care Education/Training Program

Abigail Elizabeth Huang, MD is a medicare enrolled "Student In An Organized Health Care Education/training Program" physician in Portland, Oregon. Her current practice location is Ohsu, 3181 Sw Sam Jackson Park Road, Portland, Oregon. You can reach out to her office (for appointments etc.) via phone at (503) 494-8211.

Abigail Elizabeth Huang is licensed to practice in * (Not Available) (license number ) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1205276466.

Contact Information

	Abigail Elizabeth Huang, MD
	Ohsu, 3181 Sw Sam Jackson Park Road, Portland, OR 97239
	(503) 494-8211
	Not Available

Physician's Profile

Full Name	Abigail Elizabeth Huang
Gender	Female
Speciality	Student In An Organized Health Care Education/training Program
Location	Ohsu, 3181 Sw Sam Jackson Park Road, Portland, Oregon
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1205276466
Provider Enumeration Date: 07/02/2013
Last Update Date: 05/30/2018

Medicare PECOS Information:

PECOS PAC ID: 7810282217
Enrollment ID: I20170908002244

Medical Identifiers

Medical identifiers for Abigail Elizabeth Huang such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1205276466	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	2016-00584 (North Carolina)	Secondary
390200000X	Student In An Organized Health Care Education/training Program	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Abigail Elizabeth Huang is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Abigail Elizabeth Huang, MD Ohsu, 3181 Sw Sam Jackson Park Road, Portland, OR 97239 Ph: (503) 494-8211	Abigail Elizabeth Huang, MD Ohsu, 3181 Sw Sam Jackson Park Road, Portland, OR 97239 Ph: (503) 494-8211

News Archive

Men with fibromyalgia symptoms less likely to receive diagnostic tests

Fibromyalgia is a complex illness to diagnose and to treat. There is not yet a diagnostic test to establish that someone has it, there is no cure and many fibromyalgia symptoms - pain, fatigue, problems sleeping and memory and mood issues - can overlap with or get mistaken for other conditions. A new Mayo Clinic study suggests that many people who have fibromyalgia, especially men, are going undiagnosed.

MORE intervention reduces pain and opioid misuse

With nearly one-third of Americans suffering from chronic pain, prescription opioid painkillers have become the leading form of treatment for this debilitating condition. Unfortunately, misuse of prescription opioids can lead to serious side effects-including death by overdose.

JAX, Tufts University unveil new mammalian genetics track for PhD students

The Jackson Laboratory, Sackler School of Graduate Biomedical Sciences at Tufts, and Tufts University School of Medicine have unveiled a new mammalian genetics track for PhD students. The joint track offers students in-depth research and training at both JAX and Tufts.

Sens. Gregg, Baucus and Rep. Braley: Health care reform should happen

News outlets reports on the health care opinions of several lawmakers, including Sen. Judd Gregg, R-N.H., Sen. Max Baucus, D-Mont., and Rep. Bruce Braley, D-Iowa.

Constella® (linaclotide), for the symptomatic treatment of Irritable Bowel Syndrome with Constipation (IBS-C), is now available in Germany, UK and Nordic countries

Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced the launch of Constella® (linaclotide 290mcg capsules once daily), the first approved prescription therapy in a new class of treatments for adults suffering from moderate to severe IBS-C,(1) in Europe. Constella® is now available in Germany, the UK and Nordic countries and is expected to be launched in several other European countries in 2013.

Abigail Elizabeth Huang, MD - Medicare Student in an Organized Health Care Education/Training Program in Portland, OR